After hitting the all-time high sales volume of 1 million units in FY19, the CV sector has not been able to surpass that ...

However, the company stated that its revenue from operations registered a growth of 66.90% to ₹534.70 Crore in Q3FY25.

The revenue increased by 8% YoY to ₹11,995 crores against ₹11,066 crores in Q3 FY24 due to strong demand in the market.

Today, majors across segments including Godfrey Phillips, United Breweries, Senco Gold, Reliance Infra, Hindalco, Healthcare ...

For Ashok Leyland, margin expansion, driven by a better sales mix and pricing power, has boosted investor sentiment. With ...

The top management has also revealed plans to invest INR 500 crore in Optare PLC, the holding company of Ashok Leyland’s ...

Natco Pharma plans to launch its CTPR products very shortly, which is estimated to have a market size of over ₹2,000 crore in India. Natco Pharma shares surged after the drug maker unveiled the first ...

Ashok Leyland (AL; CMP: Rs 219.35; Market Cap: Rs 64,412 crore, Rating: Overweight) reported results for Q3FY2025, which were ...

The Q3FY25 revenue from operations stood at Rs 11,995 crore, an increase of over 8% from Rs 11,066 crore reported in the ...